The Great Outdoors Fund Secures Donation from Yamaha Motor Corporation USA to Leverage with Great American Outdoors Act Funding

DALLAS, Feb. 18, 2021 /PRNewswire/ — The Great Outdoors Fund has been awarded a grant from Yamaha’s Outdoor Access Initiative to match with funding from the Great American Outdoors Act and restore Lotus Camp, a run-down campground on the Kisatchie National Forest in Central Louisiana.

<a…

DALLAS, Feb. 18, 2021 /PRNewswire/ — The Great Outdoors Fund has been awarded a grant from Yamaha’s Outdoor Access Initiative to match with funding from the Great American Outdoors Act and restore Lotus Camp, a run-down campground on the Kisatchie National Forest in Central Louisiana.

The Great Outdoors Fund was established to help public agencies address the growing gap between needs and resources by unleashing private sector capital to update and improve outdoor recreation infrastructure and increase access to our public lands and waters.

Great American Outdoors Act funding matched by The Great Outdoors Fund and Yamaha Motor Corporation USA for new project.

«We’re excited to facilitate a donation from Yamaha and bring greater return on tax-payer dollars appropriated through the Great American Outdoors Act,» said Lori McCullough, Founder of The Great Outdoors Fund. «The new law encourages donations and relevant public-private partnerships which is exactly what we’ve established between Yamaha and the USDA Forest Service in order to build back Lotus Camp better than it’s been before.»

Lotus Camp is accessible from the Sandstone Trail, a multi-use trail popular with mountain bikers, horseback riders, and a variety of off-highway vehicle enthusiasts.

«For years the Forest Service has wanted to refurbish Lotus Camp and improve the conditions of this site to provide a better experience for the visitors to this Forest,» said Lisa Lewis, Forest Supervisor of the Kisatchie National Forest. «With the passage of the Great American Outdoors Act we have funds to address our backlog maintenance.  Thankfully, with the support we received from The Great Outdoors Fund and the generous donation from Yamaha, now we’ll be able to install new campfire rings, picnic tables, an information kiosk, and improve the grade and drainage of the entrance road and Sandstone trail.»

«Yamaha has contributed nearly $4.5 million to support projects that create and improve Americans’ opportunities to enjoy the great outdoors,» said Steve Nessl, Yamaha Motorsports Marketing Manager. «We are happy The Great Outdoors Fund is able to fully leverage the Outdoor Access Initiative grant and be among the first in the nation to attract funding from the Great American Outdoors Act.»

The restoration and enhancements made to Lotus Camp and the Sandstone Trail will be completed by no later than June 1, 2021.

For more information, please visit thegreatoutdoorsfund.org or visit us on Instagram at @thegreatoutdoorsfund.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/the-great-outdoors-fund-secures-donation-from-yamaha-motor-corporation-usa-to-leverage-with-great-american-outdoors-act-funding-301230435.html

SOURCE The Great Outdoors Fund

Analysis Reveals Risk of Stalled Economic Recovery Among Black Workers

WASHINGTON, Feb. 18, 2021 /PRNewswire/ — While American workers as a whole, particularly women, saw incremental growth in living-wage job opportunities in January, Black workers lost ground, according to an analysis by the Ludwig Institute for Shared Economic Prosperity (LISEP).

WASHINGTON, Feb. 18, 2021 /PRNewswire/ — While American workers as a whole, particularly women, saw incremental growth in living-wage job opportunities in January, Black workers lost ground, according to an analysis by the Ludwig Institute for Shared Economic Prosperity (LISEP).

LISEP’s January True Rate of Unemployment (TRU) report found that the rate of Black workers who are «functionally unemployed» increased from 30.2% to 30.7%. This paints a different picture than the Bureau of Labor Statistics (BLS) report, which presented an improving unemployment picture for Blacks in the workforce.

«While we are encouraged that the overall percentage of functionally unemployed Americans is slightly better, we remain concerned that the racial inequality gap is growing,» said LISEP Chair Gene Ludwig. «There are still far too many American families suffering due to the inability to find a living-wage job, particularly among Americans of color.»

Each month, LISEP issues the TRU report, which measures the percentage of American workers who are «functionally unemployed» – defined as those who are jobless, or who are seeking full-time work but unable to secure a position that earns above poverty-level wages. The TRU for January, at 24.4%, is a 0.7% improvement over the December report and the lowest since the 23.8% TRU in March 2020. By contrast, BLS reported an unemployment rate of 6.3% for January, an improvement over the 6.7% December rate.

The good news in the January TRU report includes gains for women in the workforce, who saw the biggest improvement, dropping from 30.4% in December to 28.5% in January. Hispanic workers also saw some improvement, from 31.6% to 29.9%, and White workers saw marginal improvement, from 22.7% to 22.3%. But Black workers were worse off, with TRU rising to 30.7% from 30.2%, while the BLS report presented an improving unemployment picture for Blacks in the workforce, dropping from 9.9% in December to 9.2% in January.

This, Ludwig said, is an indication that while more Black workers are finding jobs, they are largely low-wage positions that fail to lift workers above the poverty level.

«While we are inching closer to pre-pandemic employment levels, this simply is not good enough – Americans need jobs that can support a family,» said Ludwig. «The pending COVID relief package is not only a necessity to relieve suffering among families across the nation, but it is an opportunity. It’s an opportunity to begin closing the income inequality gap, address racial inequalities, and to build back an economy where everyone can participate, equally.»

Meanwhile, some gradual reopening of the service industry seems to have aided in improving the TRU levels for workers with lower educational attainment levels. For those with less than a high-school diploma, the TRU improved by 2.6 percentage points, although it still remains exceedingly high, at 46.7%. For those with only a high-school diploma, the rate improved to 29.8%, compared to 30.5% in December.

LISEP issued the white paper «Measuring Better: Development of ‘True Rate of Unemployment’ Data as the Basis for Social and Economic Policy» upon announcing the new statistical measure in October. The paper and methodology can be viewed here. LISEP issues TRU one to two weeks following the release of the BLS unemployment report, which occurs on the first Friday of each month. The TRU rate and supporting data are available on the LISEP website at www.lisep.org.  

LISEP was created in 2019 by Ludwig and his wife, Dr. Carol Ludwig. The mission of LISEP is to improve the economic well-being of middle- and lower-income Americans through research and education, and seeks to advance the dialogue around policy solutions to improve the well-being of all Americans.

In addition to his role as LISEP chair, Gene Ludwig is founder of the Promontory family of companies and Canapi LLC, the nation’s largest financial technology venture fund. He is the CEO of Promontory Financial Group and chairman and CEO of Promontory MortgagePath, a technology-based mortgage fulfillment and solutions company. Ludwig is the former vice chairman and senior control officer of Bankers Trust New York Corp., and served as the U.S. Comptroller of the Currency from 1993 to 1998. He is also author of the book The Vanishing American Dream, which investigates the economic challenges facing low- and middle-income Americans. It was released in September 2020 by Disruption Books.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/analysis-reveals-risk-of-stalled-economic-recovery-among-black-workers-301230584.html

SOURCE Ludwig Institute for Shared Economic Prosperity

CED Report Reveals Severity of America’s Deteriorating Infrastructure, Provides Modernization Plan for Public and Private Sectors

WASHINGTON, Feb. 18, 2021 /PRNewswire/ — Neglected for too long, America’s severe infrastructure needs must finally be placed at the top of the US policy agenda. To that end, the Committee for Economic Development of The Conference Board (CED) has released a new, comprehensive

WASHINGTON, Feb. 18, 2021 /PRNewswire/ — Neglected for too long, America’s severe infrastructure needs must finally be placed at the top of the US policy agenda. To that end, the Committee for Economic Development of The Conference Board (CED) has released a new, comprehensive report with several policy recommendations to address this building crisis.

From highways and bridges to air traffic control and water resources, and from energy production to broadband internet access, nearly every facet of the country’s infrastructure is below global standards and deteriorating daily. The devastating impact of COVID-19 has not only underscored the shortfalls in the system – for example, by highlighting the inequities in access to reliable, high-speed internet. The pandemic has also increased the urgency of raising America’s global competitiveness.

A US Infrastructure Plan: Building for the Long Haul lays out principles for closing the infrastructure gap and details public and private sector policy recommendations to return the US to world-class status.

«Modernizing our infrastructure is one of the few issues that enjoys broad bipartisan support, so both sides can work together to comprehensively address this glaring issue,» said Lori Esposito Murray, President of CED. «The large number of areas that fall under the infrastructure rubric demonstrates its importance to our economy. A sharp focus on its role and key issues can lead the nation toward faster economic growth and job creation, environmental protection, equality of opportunity, shared prosperity, and eventual public savings.»

Not only is infrastructure a bipartisan issue, but it also crosses public-private lines in unexpected ways. While government is sometimes believed to be the source of all infrastructure weaknesses, private-sector responsibility is more salient in some areas.

As the report details, reasoned principles to close the substantial US infrastructure gap include:

  • Improve infrastructure planning and decision making through cost-benefit analysis and increased coordination. Given the substantial role of federal financing in many state and local infrastructure projects, and the regional, multi-jurisdiction impacts of infrastructure, smart project selection requires substantial coordination in long-term design and planning. That includes bringing together private and public stakeholders across different levels of government and political or geographic boundaries. Improved project selection would reflect data-driven management of both existing and planned infrastructure assets, identifying the true needs, potential benefits, and life-cycle costs—and comparing the relative net value of maintenance or upgrades to existing infrastructure against the construction of new and additional capacity.
  • Encourage and facilitate innovation. As technology advances, Federal infrastructure policy must respond, looking beyond particular categories of infrastructure, past allocation formulas, and rules of thumb. Instead, it must choose assets and solutions that best meet a community’s or region’s particular needs, recognizing that the best choices will change with the changing times. For example, dedicated funding for roads or rails will lead to rigid road- or rail-based solutions in proportion to the funding provided last year or 10 years ago, even if a different balance or approach—perhaps one not yet recognized, or more emphasis on data infrastructure—could better achieve the region’s goals.
  • Modernize and streamline regulation. CED has consistently advocated «smart regulation,» subjecting new regulations to cost-benefit analysis and reviewing existing regulations for continuing cost-effectiveness. A smart regulation approach could reduce delays and cut through multiple layers of jurisdiction to ensure that review and permitting of projects address all important concerns, and that net benefits are maximized over time at all levels of government.
  • Achieve appropriate private-sector involvement in public infrastructure choices. Much of the nation’s infrastructure investment is in the nature of public goods, which are (or should be, in the public interest) available to all without restriction. However, in some instances, the services provided through infrastructure can be priced, and should be provided on the basis of willingness to pay. In those instances, well-designed public-private partnerships (PPPs) can foster efficiency, innovation, and long-term performance while transferring certain financial risks—like cost overruns and delays—from the public to private investors.
  • Explore alternative approaches for utilizing private investment resources. Private-sector funding, particularly through tax-exempt municipal debt issuances, is central to current US infrastructure financing. However, creative financing mechanisms like Transportation Infrastructure Finance and Innovation Act assistance and the currently lapsed Build America Bonds program have encouraged efficient upfront utilization of private investment resources, including by allowing more nongovernmental investors to participate in infrastructure project financing. Policymakers should explore, evaluate, and support such creative alternatives.
  • Incorporate user fees to gauge the value of, and finance, infrastructure projects. «User-pay» models can not only promote efficient project choices and achieve sustainable financing, but also ascribe the cost to the people who most directly benefit. Where appropriate, user-pay models yield better and fairer outcomes.
  • Incorporate climate risk into evaluations of potential infrastructure investments. Changes in climate pose potentially sizable risks to the apparent value propositions of long-term assets, even though the timing and severity of those risks are uncertain. Serious cost-benefit analysis must include preparation for climate-related stresses or hazards—including more extreme weather events, such as increased flood, wildfire, and drought risks.

The entire report – the latest in a series of CED Solutions Briefs – can be accessed here. Contact the Committee for Economic Development of The Conference Board for inquiries, including interviews.

About CED
The Committee for Economic Development of The Conference Board (CED) is the nonprofit, nonpartisan, business-led public policy center that delivers well-researched analysis and reasoned solutions in the nation’s interest. CED Trustees are chief executive officers and key executives of leading US companies who bring their unique experience to address today’s pressing policy issues. Collectively they represent 30+ industries, over a trillion dollars in revenue, and over 4 million employees. www.ced.org 

About The Conference Board
The Conference Board is the member-driven think tank that delivers trusted insights for what’s ahead. Founded in 1916, we are a non-partisan, not-for-profit entity holding 501 (c) (3) tax-exempt status in the United States. www.conference-board.org

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/ced-report-reveals-severity-of-americas-deteriorating-infrastructure-provides-modernization-plan-for-public-and-private-sectors-301231089.html

SOURCE Committee for Economic Development of The Conference Board (CED)

THE BIG THIRST Author Charles Fishman Joins JAIN for a Timely Conversation About Water

FRESNO, Calif., Feb. 18, 2021 /PRNewswire-PRWeb/ — Jain Irrigation, Inc., the world leader in irrigation technology, is proud to host author Charles Fishman in a special episode of its twice-weekly JAIN Irrigation Training Series free webinars titled «THE BIG THIRST Author Charles Fishman Joins JAIN for a Timely Conversation About Water,» on Friday, February 26, 2021, at noon Pacific Time. The webinar is open…

FRESNO, Calif., Feb. 18, 2021 /PRNewswire-PRWeb/ — Jain Irrigation, Inc., the world leader in irrigation technology, is proud to host author Charles Fishman in a special episode of its twice-weekly JAIN Irrigation Training Series free webinars titled «THE BIG THIRST Author Charles Fishman Joins JAIN for a Timely Conversation About Water,» on Friday, February 26, 2021, at noon Pacific Time. The webinar is open to the public and free to attend by registering online at https://jainsusa.com/training/the-big-thirst/.

February 2021 marks the tenth anniversary of the publication of THE BIG THIRST: The Secret Life and Turbulent Future of Water. JAIN Irrigation Training Series host Richard Restuccia will talk with Charles Fishman about what predictions THE BIG THIRST got right, where it missed and why the next ten years will be the most intense and innovative period for water in history. They’ll also discuss Fishman’s most recent book, ONE GIANT LEAP: The Impossible Mission that Flew Us to the Moon, and lessons from the historic space program for the water industry.

The popular free JAIN Irrigation Training Series is a live twice-weekly webinar designed for agriculture dealers, landscape distributors, contractors, and other irrigation professionals presented each Wednesday and Friday. The recorded webinars’ free streaming video playbacks are available on the Jain Irrigation, Inc. website and in audio podcast format for streaming or download through Apple Podcasts, Google Podcasts, Spotify iHeart Radio, Stitcher, and TuneIn. For more information, visit https://jainsusa.com/trainings/.            

About Charles Fishman

Charles Fishman is an acclaimed author, journalist, and historian. His books include One Giant Leap, A Curious Mind (with Brian Grazer), The Wal-Mart Effect, and The Big Thirst. He is a three-time winner of the Gerald Loeb Award, the most prestigious prize in business journalism.

ABOUT JAIN IRRIGATION
Jain is a fully integrated global food/plant production company recognized by Harvard Business to be one of five global sustainability champions and the G-20 for lifting people out of poverty. Our irrigation manufacturing capabilities include everything from behind the pump to the flush valve at the end of the lateral and everything in between, including drip irrigation. We lead the industry in manufacturing technology, owning both our extrusion and mold manufacturing equipment providers. Jain conducts plant science research globally across various food crops and is staffed with some of the world’s leading research scientists. With the Gandhi Library, Jain now houses the prominent collection of the world’s best plant science knowledge in a single facility. Our agronomic knowledge is integrated from our world-class tissue culture operations through our food processing businesses. We research, educate, advance, manufacture, finance, propagate plants, and purchase produce for processing, all to fulfill the Jain mission, «leave this world better than you found it.»

Media Contact

Richard Restuccia, Jain Irrigation, +1 858 952-6038, Rrestuccia@jainsusa.com

Twitter

 

SOURCE Jain Irrigation

Universal Music Group Launches Virgin Music Label And Artist Services

SANTA MONICA, Calif., Feb. 18, 2021 /PRNewswire/ — Universal Music Group (UMG), the world leader in music based-entertainment, today announced the launch of Virgin Music Label & Artist Services, a new global network delivering premium and flexible artist and label services to the industry’s most dynamic entrepreneurs and independent talent worldwide, inspired and influenced by the spirit and ethos of the iconic Virgin Records label.

<div class="PRN_ImbeddedAssetReference"…

SANTA MONICA, Calif., Feb. 18, 2021 /PRNewswire/ — Universal Music Group (UMG), the world leader in music based-entertainment, today announced the launch of Virgin Music Label & Artist Services, a new global network delivering premium and flexible artist and label services to the industry’s most dynamic entrepreneurs and independent talent worldwide, inspired and influenced by the spirit and ethos of the iconic Virgin Records label.

Sir Lucian Grainge, Chairman and CEO of UMG, said: «Virgin has long been a name synonymous with disruptive innovation, musical creativity and entrepreneurialism. We are thrilled to announce the reinvigoration of this iconic music brand as a new model for global distribution and label services – combining UMG’s unrivalled regional executive teams with dedicated resources and best-in-class services and technology, to help foster long-term partnerships and deliver global success for the next generation of independent labels and artist talent. In total, this global launch represents an important evolution of our industry-leading strategy to be an accelerator and vital partner for the music’s best independent artists and entrepreneurs.»

Sir Richard Branson, Virgin Founder, said: «I’m proud that half a century after we opened our first independent record shop in London, the Virgin Music name continues to represent the very best entrepreneurs, innovators, and artists from the world of music today.»

Founded in 1972 in the U.K. by Branson, Virgin Records has helped redefine music culture for almost half a century. Independent music distribution and disruption have been a key catalyst in Virgin’s global success throughout its history: from its pioneering roots in prog, reggae, punk and new wave; with distributed labels, including Frontline, Stiff, Charisma and Circa; to the creation of Caroline and Astralwerks, both now successful divisions within the UMG label family.

Virgin Records also served as home to some of the most influential and reverential artists of the past century, including: David Bowie; The Sex Pistols; Aaliyah; The Rolling Stones; George Michael; Janet Jackson; Lenny Kravitz; Culture Club; Massive Attack; and the Spice Girls.

To build on its rich cultural and musical legacy, Virgin Music Label & Artist Services will be led in each region by highly skilled executive teams, providing fully resourced regional hubs that combine UMG’s industry-leading technology platforms, specialist local networks and expertise with UMG’s global strength and reach, alongside a suite of resources to help position labels and artists for long-term success globally and to empower the next generation of independent artists and labels to reach new audiences around the world.

Effective immediately, Virgin Music Label & Artist Services will provide artists global solutions, with fully staffed operations already established in the world’s top five music markets (U.S., Japan, U.K., Germany, France) and across Latin America, the world’s fastest-growing region for the past five years. Additional operations will launch in the coming months. Regional details include:

In the U.S., Caroline will be renamed Virgin Label & Artist Services. It will continue under the leadership of Jacqueline Saturn, who becomes President, Virgin Music Label & Artist Services, reporting to Capitol Music Group President and COO, Michelle Jubelirer. The company offers independent artists and labels the resources of UMG, on top of a winning team of strategists and marketers, resulting in hugely successful partnerships such as: Motown’s innovative alliance with Atlanta-based Quality Control Music, leading to the rise of global superstar such as Lil Baby10K Projects whose break out artists include Trippie Redd, Internet Money, Surfaces and iann dior. Other successful partnerships with artists and label include Clairo through the Fader Label, SHAED through Photo Finish, Black Pumas through ATO Records. NCT127 and SuperM through SM Entertainment and independent artists E-40, Mac Demarco, Anson Seabra, Judah & the Lion and others.

In the U.K., highly respected industry executive Vanessa Higgins has been appointed as MD, Virgin Music Label & Artist Services UK, effective immediately.  She joins UMG from Regent Street Records, the independent record label and music publishing company she founded in 2014, after spending 15 years as a touring musician. Higgins has a long history of working with independent artists, having also represented their interests as a board member of the BPI (the U.K. record labels’ trade association) since 2015, and as Director of the BPI’s innovation hub between 2016-19. She currently serves as a mentor for Abbey Road Red’s technology and innovation seeding programme. Higgins will report to David Joseph, Chairman & CEO, Universal Music UK. Labels and artists that will be distributed from the U.K. will include: Mixtape Madness, Brit Award nominees D Block Europe, Midas The Jagaban, Digga D, Potter Payper & Bugzy Malone, Fiction, Billie Marten, The Amazons and The Big Moon, Rema, StayFleeGetLizzy, Tiffany Calver, EGA, Faceless and NQ.

In France, the new evolved division will be built from the foundations of Caroline France, with operations led by Thomas Lorain who has been appointed as MD, Virgin Music Labels & Artist Services France effective immediately. Lorain has overseen Caroline France since 2014 and currently manages a team of sixteen. With the input and support of Universal Music France CEO, Olivier Nusse since 2016, Caroline France has quickly  become a leading home for the incubation of new artists and independent labels within France, delivering breakthrough domestic success for artists including; Alpha Wann (Don Dada Records), Carpenter Brut (No Quarter), Grand Corps Malade (Anouche Productions), Kaaris (OG Record/Lutèce), Polo & Pan (Hamburger Records / Ekleroshock), RimK (Frenesik) and Wejdene (Guette Music / Caroline France). On top of the artists already distributed, the first labels to join Virgin Music France will include: Danger Productions (Captaine Roshi), Guette Music (Larse) Profile de face (Lewis OfMan, Pretty Boy Aaron) and Think Zik! (Imany, Anwar).

In Germany alongside other markets across Central Europe, existing Caroline operations will be incorporated and expanded into Virgin Music Label & Artist Services. The new division in Germany will be led by Tina Adams, who will assume the role of Label Manager effective immediately. The label will be based in Berlin and will report to Frank Briegmann, Chairman & CEO Universal Music Central Europe and Deutsche Grammophon. The new division will operate alongside domestic frontline label Virgin Records Germany.

In Latin America & Iberia, Virgin Music Label & Artist Services will launch in early 2021 across a handful of key markets including Mexico, Spain and Latin operations in the U.S. The label will have dedicated teams and resources based in Los Angeles, Miami and Mexico City and will focus on supporting the next wave of independent Latin talent, labels, influencers and entrepreneurs globally. Virgin Music Label & Artist Services Latin America will be the first fully integrated label services division worldwide for Latin music, providing artists, labels and partners with access to local and international marketing services, Live and management services through GTS, Merchandising through Bravado and Publishing services alongside UMPG. This unique suite of services will enable Latin artists to take a bespoke and cohesive approach to releasing music, visual content, podcasts, physical product and merchandise in order to provide the best fan experiences.

Virgin Music Latin America will be led by Víctor González, who has been appointed to the position of President, Virgin Music LATAM & Iberia, effective immediately. A long-standing and highly respected executive, González has worked for UMG for more than 22 years, and most recently held the position of President, Universal Music Latin Entertainment (UMLE). He will be based in Los Angeles and will report to Jesús López, Chairman & CEO Latin America & Iberian Peninsula.

In Japan, Virgin Music Label & Artist Services Japan will launch, effective immediately, and will broaden the existing capabilities of Caroline Japan, which will be combined into the new division led by highly experienced executive Hirokazu Tanaka, reporting to Naoshi Fujikura, President and CEO, Universal Music Japan.  The new division will operate alongside domestic frontline label Virgin Music.

Caroline International’s award-winning label services operation based in the U.K. will be renamed Virgin Music Label & Artist Services, effective immediately, under the continued leadership of MD’s Michael Roe and Jim Chancellor, and will support the leaders of Virgin worldwide to ensure that Virgin Music Label & Artist Services continues to represent and distribute the best in independent talent and labels around the world. In 2020, Caroline International delivered major international chart success for Caroline artists including: Aitch, The Big Moon; Internet Money; Zoe Wees (Via UM Germany) and D-Block Europe amongst others. Artists and Labels to be distributed globally via Virgin Music Label & Artist services include: Because Music (Christine & The Queens, Major Lazer –global markets outside of France), Van Morrison, Steven Wilson, Sophie Hunger, Peter Gabriel, Tame Impala (ex UK, US & Australia), Iggy Pop, Underworld and DAVE (excluding UK & US).

Notes to editors:

About Universal Music Group
Universal Music Group (UMG) is the world leader in music-based entertainment, with a broad array of businesses engaged in recorded music, music publishing, merchandising and audiovisual content in more than 60 countries. Featuring the most comprehensive catalog of recordings and songs across every musical genre, UMG identifies and develops artists and produces and distributes the most critically acclaimed and commercially successful music in the world. Committed to artistry, innovation and entrepreneurship, UMG fosters the development of services, platforms and business models in order to broaden artistic and commercial opportunities for our artists and create new experiences for fans. Universal Music Group is a Vivendi company. Find out more at: http://www.universalmusic.com.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/universal-music-group-launches-virgin-music-label-and-artist-services-301231074.html

SOURCE Universal Music Group

Rodeo Hyundai Highlights 2021 Hyundai Sedans in February Savings

SURPRISE, Ariz., Feb. 18, 2021 /PRNewswire-PRWeb/ — Sedan savings are in full swing at Rodeo Hyundai this February with offers on fan-favorite models. Shoppers looking for their next sedan in the Surprise and Buckeye areas will be able to find a new Hyundai sedan for an affordable price at the Rodeo Hyundai dealership.

Now through March 1, Rodeo Hyundai is offering lease and finance incentives on…

SURPRISE, Ariz., Feb. 18, 2021 /PRNewswire-PRWeb/ — Sedan savings are in full swing at Rodeo Hyundai this February with offers on fan-favorite models. Shoppers looking for their next sedan in the Surprise and Buckeye areas will be able to find a new Hyundai sedan for an affordable price at the Rodeo Hyundai dealership.

Now through March 1, Rodeo Hyundai is offering lease and finance incentives on top-rated Hyundai sedan models. The dealership is offering 36-month lease opportunities on select 2021 Hyundai Sonata SE entries with $159 due per month and $3,689 due at signing. Those looking for a finance option may be eligible to take advantage of a 0% Annual Percentage Rate (APR) for up to 60 months on qualifying Sonata models.

Budget-minded lease opportunities are also available on select 2021 Hyundai Elantra models on the Rodeo Hyundai lot. Select Elantra variants are available with a 36-month lease contract with $189 due per month and $2,399 due at signing. Qualifying shoppers may be eligible to receive a 0.9% APR for up to 60 months on select Elantra models.

Qualification for all offers and incentives is subject to approval by Hyundai Motor Finance. Shoppers looking for their next vehicle can start their search for a new Hyundai sedan online on the Rodeo Hyundai website. Rodeo Hyundai offers online shopping tools that allow prospective buyers to complete their entire purchase or lease online, without having to stop by the dealership.

Anyone can view the lineup of available Hyundai sedans on the Rodeo Hyundai website, rodeohyundai.com. The Rodeo Hyundai dealership is located at 12925 N. Autoshow Ave. in Surprise, AZ. Individuals looking for guidance through their online vehicle purchase or who have questions about available inventory can contact a member of the Rodeo Hyundai team by calling 623-214-4100.

Media Contact

Earnhardt Marketing, Rodeo Hyundai, 623-214-4100, press@earnhardt.com

 

SOURCE Rodeo Hyundai

Hundreds of People at Risk for Severe COVID-19 Avoid Hospitalization with New Treatment

BRONX, N.Y., Feb. 18, 2021 /PRNewswire-HISPANIC PR WIRE/ — Last December, 70-year-old Bronx resident Irma Vega got COVID-19. Like 52 percent of people living in…

BRONX, N.Y., Feb. 18, 2021 /PRNewswire-HISPANIC PR WIRE/ — Last December, 70-year-old Bronx resident Irma Vega got COVID-19. Like 52 percent of people living in the Bronx, Vega had multiple chronic conditions, meaning her case of COVID-19 could easily become life-threatening. After her positive test, she arrived at Montefiore Medical Center to begin monoclonal antibody treatment.

Dr. Priya Nori, director of the Antibiotic Stewardship Program, an infectious disease specialist at Montefiore Health System, and associate professor of medicine at Albert Einstein College of Medicine

Monoclonal antibodies are created in a lab and function like naturally occurring antibodies, fighting infections before they spread. Studies show that when monoclonal antibodies are given intravenously to high-risk people diagnosed early with COVID-19, it can prevent them from experiencing severe symptoms that lead to hospitalizations.

«COVID-19 is a horrible illness, but I trusted the doctors and nurses,» said Vega. «I started monoclonal antibodies and my symptoms never got worse. I never needed to go to the hospital.»

Today more than 470 patients like Vega have benefited from Montefiore’s monoclonal antibody program, 93 percent of whom avoided worsening symptoms that would have required a visit to the hospital.

«Longstanding inequities and chronic disease have led to high COVID-19 infection rates and significant risk of death in our borough,» said Dr. Priya Nori, director of the Antibiotic Stewardship Program, an infectious disease specialist at Montefiore Health System, and associate professor of medicine at Albert Einstein College of Medicine. «Now Bronx residents have a safe, evidence-based treatment that stops COVID-19 in its tracks and is preventing severe illness.»

In December, Dr. Nori’s team began treating patients in Montefiore’s Bronx emergency departments with monoclonal antibodies, which are developed by pharmaceutical companies and authorized by the Food and Drug Administration. Since then, Montefiore opened an infusion clinic – now the main location for this therapy – and is partnering with local nursing homes to treat their residents.

People who qualify for monoclonal antibodies have a high-risk of severe COVID-19, including people aged 65 or older, and illnesses like chronic kidney disease, diabetes, hypertension, coronary artery disease, obesity and COPD. People who are immunocompromised due to diseases such as cancer, lupus or sickle cell anemia, or organ transplant recipients, are also candidates for treatment. Pregnant women and high-risk patients under age 21 may also qualify.

The monoclonal antibody treatment is given using IV therapy, administered through a vein in the arm, for about an hour. Patients are evaluated by a nurse practitioner and then monitored for any allergic reactions, which are extremely rare.  The appointment takes about three hours to complete; afterward patients receive a follow-up phone visit. Less than two weeks later, a telehealth appointment is completed with an infectious disease doctor who reviews recovery and symptoms.

«Patients come in with fear of COVID-19 and leave with hope because of this treatment,» said Susan Sakalian, Oncology Certified Nurse at Montefiore Medical Center. «It is a huge step forward from where we were in March 2020. The infusions keep people from needing emergency care, and that’s an invaluable resource for our patients and their families.»

For more information about the monoclonal antibodies treatment, please visit  covid19.montefiore.org/monoclonal-antibody-therapy-montefiore#main-content.

About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 10 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2020-21 academic year, Einstein is home to 721 M.D. students, 178 Ph.D. students, 109 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,900 full-time faculty members located on the main campus and at its clinical affiliates. In 2020, Einstein received more than $197 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Photo – https://mma.prnewswire.com/media/1440703/Nori_Priya_2013_05_55.jpg
Logo – https://mma.prnewswire.com/media/675671/Montefiore_Logo.jpg

SOURCE Montefiore Health System

Hundreds of People at Risk for Severe COVID-19 Avoid Hospitalization with New Treatment

BRONX, N.Y., Feb. 18, 2021 /PRNewswire-HISPANIC PR WIRE/ — Last December, 70-year-old Bronx resident Irma Vega got COVID-19. Like 52 percent of people living in…

BRONX, N.Y., Feb. 18, 2021 /PRNewswire-HISPANIC PR WIRE/ — Last December, 70-year-old Bronx resident Irma Vega got COVID-19. Like 52 percent of people living in the Bronx, Vega had multiple chronic conditions, meaning her case of COVID-19 could easily become life-threatening. After her positive test, she arrived at Montefiore Medical Center to begin monoclonal antibody treatment.

Dr. Priya Nori, director of the Antibiotic Stewardship Program, an infectious disease specialist at Montefiore Health System, and associate professor of medicine at Albert Einstein College of Medicine

Monoclonal antibodies are created in a lab and function like naturally occurring antibodies, fighting infections before they spread. Studies show that when monoclonal antibodies are given intravenously to high-risk people diagnosed early with COVID-19, it can prevent them from experiencing severe symptoms that lead to hospitalizations.

«COVID-19 is a horrible illness, but I trusted the doctors and nurses,» said Vega. «I started monoclonal antibodies and my symptoms never got worse. I never needed to go to the hospital.»

Today more than 470 patients like Vega have benefited from Montefiore’s monoclonal antibody program, 93 percent of whom avoided worsening symptoms that would have required a visit to the hospital.

«Longstanding inequities and chronic disease have led to high COVID-19 infection rates and significant risk of death in our borough,» said Dr. Priya Nori, director of the Antibiotic Stewardship Program, an infectious disease specialist at Montefiore Health System, and associate professor of medicine at Albert Einstein College of Medicine. «Now Bronx residents have a safe, evidence-based treatment that stops COVID-19 in its tracks and is preventing severe illness.»

In December, Dr. Nori’s team began treating patients in Montefiore’s Bronx emergency departments with monoclonal antibodies, which are developed by pharmaceutical companies and authorized by the Food and Drug Administration. Since then, Montefiore opened an infusion clinic – now the main location for this therapy – and is partnering with local nursing homes to treat their residents.

People who qualify for monoclonal antibodies have a high-risk of severe COVID-19, including people aged 65 or older, and illnesses like chronic kidney disease, diabetes, hypertension, coronary artery disease, obesity and COPD. People who are immunocompromised due to diseases such as cancer, lupus or sickle cell anemia, or organ transplant recipients, are also candidates for treatment. Pregnant women and high-risk patients under age 21 may also qualify.

The monoclonal antibody treatment is given using IV therapy, administered through a vein in the arm, for about an hour. Patients are evaluated by a nurse practitioner and then monitored for any allergic reactions, which are extremely rare.  The appointment takes about three hours to complete; afterward patients receive a follow-up phone visit. Less than two weeks later, a telehealth appointment is completed with an infectious disease doctor who reviews recovery and symptoms.

«Patients come in with fear of COVID-19 and leave with hope because of this treatment,» said Susan Sakalian, Oncology Certified Nurse at Montefiore Medical Center. «It is a huge step forward from where we were in March 2020. The infusions keep people from needing emergency care, and that’s an invaluable resource for our patients and their families.»

For more information about the monoclonal antibodies treatment, please visit  covid19.montefiore.org/monoclonal-antibody-therapy-montefiore#main-content.

About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 10 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2020-21 academic year, Einstein is home to 721 M.D. students, 178 Ph.D. students, 109 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,900 full-time faculty members located on the main campus and at its clinical affiliates. In 2020, Einstein received more than $197 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

Photo – https://mma.prnewswire.com/media/1440703/Nori_Priya_2013_05_55.jpg
Logo – https://mma.prnewswire.com/media/675671/Montefiore_Logo.jpg

SOURCE Montefiore Health System

Hundreds of People at Risk for Severe COVID-19 Avoid Hospitalization with New Treatment

BRONX, N.Y., Feb. 18, 2021 /PRNewswire/ — Last December, 70-year-old Bronx resident Irma Vega got COVID-19. Like 52 percent of people living in the <span…

BRONX, N.Y., Feb. 18, 2021 /PRNewswire/ — Last December, 70-year-old Bronx resident Irma Vega got COVID-19. Like 52 percent of people living in the Bronx, Vega had multiple chronic conditions, meaning her case of COVID-19 could easily become life-threatening. After her positive test, she arrived at Montefiore Medical Center to begin monoclonal antibody treatment.

Monoclonal antibodies are created in a lab and function like naturally occurring antibodies, fighting infections before they spread. Studies show that when monoclonal antibodies are given intravenously to high-risk people diagnosed early with COVID-19, it can prevent them from experiencing severe symptoms that lead to hospitalizations.

«COVID-19 is a horrible illness, but I trusted the doctors and nurses,» said Vega. «I started monoclonal antibodies and my symptoms never got worse. I never needed to go to the hospital.»

Today more than 470 patients like Vega have benefited from Montefiore’s monoclonal antibody program, 93 percent of whom avoided worsening symptoms that would have required a visit to the hospital.

«Longstanding inequities and chronic disease have led to high COVID-19 infection rates and significant risk of death in our borough,» said Dr. Priya Nori, director of the Antibiotic Stewardship Program, an infectious disease specialist at Montefiore Health System, and associate professor of medicine at Albert Einstein College of Medicine. «Now Bronx residents have a safe, evidence-based treatment that stops COVID-19 in its tracks and is preventing severe illness.»

In December, Dr. Nori’s team began treating patients in Montefiore’s Bronx emergency departments with monoclonal antibodies, which are developed by pharmaceutical companies and authorized by the Food and Drug Administration. Since then, Montefiore opened an infusion clinic – now the main location for this therapy – and is partnering with local nursing homes to treat their residents.

People who qualify for monoclonal antibodies have a high-risk of severe COVID-19, including people aged 65 or older, and illnesses like chronic kidney disease, diabetes, hypertension, coronary artery disease, obesity and COPD. People who are immunocompromised due to diseases such as cancer, lupus or sickle cell anemia, or organ transplant recipients, are also candidates for treatment. Pregnant women and high-risk patients under age 21 may also qualify.

The monoclonal antibody treatment is given using IV therapy, administered through a vein in the arm, for about an hour. Patients are evaluated by a nurse practitioner and then monitored for any allergic reactions, which are extremely rare.  The appointment takes about three hours to complete; afterward patients receive a follow-up phone visit. Less than two weeks later, a telehealth appointment is completed with an infectious disease doctor who reviews recovery and symptoms.

«Patients come in with fear of COVID-19 and leave with hope because of this treatment,» said Susan Sakalian, Oncology Certified Nurse at Montefiore Medical Center. «It is a huge step forward from where we were in March 2020. The infusions keep people from needing emergency care, and that’s an invaluable resource for our patients and their families.»

For more information about the monoclonal antibodies treatment, please visit  covid19.montefiore.org/monoclonal-antibody-therapy-montefiore#main-content.

About Montefiore Health System
Montefiore Health System is one of New York’s premier academic health systems and is a recognized leader in providing exceptional quality and personalized, accountable care to approximately three million people in communities across the Bronx, Westchester and the Hudson Valley. It is comprised of 10 hospitals, including the Children’s Hospital at Montefiore, Burke Rehabilitation Hospital and more than 200 outpatient ambulatory care sites. The advanced clinical and translational research at its medical school, Albert Einstein College of Medicine, directly informs patient care and improves outcomes. From the Montefiore-Einstein Centers of Excellence in cancer, cardiology and vascular care, pediatrics, and transplantation, to its preeminent school-based health program, Montefiore is a fully integrated healthcare delivery system providing coordinated, comprehensive care to patients and their families. For more information please visit www.montefiore.org. Follow us on Twitter and view us on Facebook and YouTube.

About Albert Einstein College of Medicine
Albert Einstein College of Medicine is one of the nation’s premier centers for research, medical education and clinical investigation. During the 2020-21 academic year, Einstein is home to 721 M.D. students, 178 Ph.D. students, 109 students in the combined M.D./Ph.D. program, and 265 postdoctoral research fellows. The College of Medicine has more than 1,900 full-time faculty members located on the main campus and at its clinical affiliates. In 2020, Einstein received more than $197 million in awards from the National Institutes of Health (NIH). This includes the funding of major research centers at Einstein in aging, intellectual development disorders, diabetes, cancer, clinical and translational research, liver disease, and AIDS. Other areas where the College of Medicine is concentrating its efforts include developmental brain research, neuroscience, cardiac disease, and initiatives to reduce and eliminate ethnic and racial health disparities. Its partnership with Montefiore, the University Hospital and academic medical center for Einstein, advances clinical and translational research to accelerate the pace at which new discoveries become the treatments and therapies that benefit patients. Einstein runs one of the largest residency and fellowship training programs in the medical and dental professions in the United States through Montefiore and an affiliation network involving hospitals and medical centers in the Bronx, Brooklyn and on Long Island. For more information, please visit www.einstein.yu.edu, read our blog, follow us on Twitter, like us on Facebook, and view us on YouTube.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/hundreds-of-people-at-risk-for-severe-covid-19-avoid-hospitalization-with-new-treatment-301231079.html

SOURCE Montefiore Health System

Impact Of Covid-19 Among Issues At Forefront Of Bloomberg Law Bankruptcy Outlook

ARLINGTON, Va., Feb. 18, 2021 /PRNewswire/ — Bloomberg Law today announced the availability of its 2021 Outlook on Bankruptcy, which incorporates news, analysis, and a subset of the most recent Practical Guidance available to subscribers on its platform. The Outlook report is accessible for complimentary download at <a target="_blank"…

ARLINGTON, Va., Feb. 18, 2021 /PRNewswire/ — Bloomberg Law today announced the availability of its 2021 Outlook on Bankruptcy, which incorporates news, analysis, and a subset of the most recent Practical Guidance available to subscribers on its platform. The Outlook report is accessible for complimentary download at http://onb-law.com/Yost50DDENB.

The 2021 Outlook on Bankruptcy features:

  • News related to the uptick in bankruptcy filings and a closer look at trends across some of the industries that have been most impacted, including hospitality and retail, which saw its largest number of filings in more than a decade.
  • Analysis by Bloomberg Law’s expert analyst team, which looks at the many lease- and rent-related bankruptcy amendments in the recently enacted Consolidated Appropriations Act, 2021 (CAA) and how the 2019 Small Business Reorganization Act has proven to be a useful tool for small businesses struggling due to the Covid-19 pandemic.
  • Practical Guidance including a temporary pandemic-related Bankruptcy Code provisions table which provides an at-a-glance overview of amendments made by Congress in the past year to the Bankruptcy Code in the Coronavirus Aid, Relief, and Economic Security (CARES) Act and the CAA.

Bloomberg Law’s complimentary 2021 Outlook on Bankruptcy incorporates news, expert analysis, and Practical Guidance.

«The Covid-19 pandemic and accompanying downturn has led to many businesses declaring bankruptcy or having to contemplate it,» said Joe Breda, President, Bloomberg Law. «These businesses must now deal with a significant number of changes to the Bankruptcy Code – and with a new administration we anticipate additional changes. Bloomberg Law’s subscribers, however, can be confident that we will stay on top of developments from Congress, the administration, and the federal judiciary to help them understand the impacts on their bottom line.»

About Bloomberg Law

Bloomberg Law helps legal professionals provide world-class counsel with access to actionable legal intelligence in a business context. Bloomberg Law delivers a unique combination of comprehensive primary and secondary source material, real-time news, expert analysis, time-saving practice tools including Practical Guidance, market data, and business intelligence. For more information, visit pro.bloomberglaw.com.

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/impact-of-covid-19-among-issues-at-forefront-of-bloomberg-law-bankruptcy-outlook-301231076.html

SOURCE Bloomberg Law